Clinical Trial Update: Esomeprazole for Treatment of GERD in Pediatric Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update on esomeprazole for treating gastroesophageal reflux disease and associated esophagitis in pediatric patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease
• Non-erosive Esophagitis

Drugs mentioned

• Esomeprazole (Esomeprazole)

Snippet

Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux Disease (GERD), Erosive Esophagitis | Phase 4 | Status: COMPLETED